Significant Ownership of JENNISON ASSOCIATES LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for JENNISON ASSOCIATES LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Beata Markowicz - Senior Vice President, Compliance
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow JENNISON ASSOCIATES LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from JENNISON ASSOCIATES LLC
Significant Ownership of JENNISON ASSOCIATES LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CABA | CABALETTA BIO INC | Common Stock | 11% | $88,092,767 | +$42,410,898 | 24,267,980 | +93% | Jennison Associates LLC | 29 May 2026 |
| INN | SUMMIT HOTEL PROPERTIES INC | REIT | 11% | $71,318,900 | +$30,289,263 | 11,653,415 | +74% | Jennison Associates LLC | 30 Jun 2026 |
| HFWA | HERITAGE FINANCIAL CORP | Common Stock | 7.8% | $87,470,735 | +$2,893,704 | 3,213,473 | +3.4% | Jennison Associates LLC | 31 Mar 2026 |
| TREE | LENDINGTREE INC | Common Stock | 7.4% | $41,910,268 | 1,020,211 | Jennison Associates LLC | 31 Mar 2026 | ||
| PVLA | PALVELLA THERAPEUTICS INC | Common Stock | 6.7% | $140,279,193 | 960,619 | Jennison Associates LLC | 30 Jun 2026 | ||
| GLDD | GREAT LAKES DREDGE & DOCK CO | Common Stock | 6.3% | $51,248,473 | -$12,429,146 | 4,274,268 | -20% | Jennison Associates LLC | 30 Sep 2025 |
| RSKD | RISKIFIED LTD-A | Common Stock | 5.1% | $26,663,472 | 5,697,323 | Jennison Associates LLC | 24 Apr 2025 | ||
| AAMI | ACADIAN ASSET MANAGEMENT INC | Common Stock | 4.3% | $109,882,509 | -$27,543,291 | 1,526,570 | -20% | Jennison Associates LLC | 30 Jun 2026 |
| AGRO | ADECOAGRO SA | Common Stock | 4.1% | $38,646,226 | 4,246,838 | Jennison Associates LLC | 31 Mar 2025 | ||
| TARS | TARSUS PHARMACEUTICALS INC | Common Stock | 4% | $124,385,809 | 1,712,124 | Jennison Associates LLC | 31 Mar 2026 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | Common Stock | 4% | $120,136,172 | -$42,866,932 | 4,980,770 | -26% | Jennison Associates LLC | 31 Mar 2026 |
| FOUR | SHIFT4 PAYMENTS INC-CLASS A | Common Stock | 3.4% | $209,846,553 | 2,335,261 | Jennison Associates LLC | 31 Dec 2024 | ||
| PLYM | PLYMOUTH INDUSTRIAL REIT INC | REIT | 3.4% | $33,535,082 | -$43,937,819 | 1,532,682 | -57% | Jennison Associates LLC | 31 Dec 2025 |
| BRDG | BRIDGE INVESTMENT GRP HDS-A | Common Stock | 3.3% | $13,776,001 | 1,471,795 | Jennison Associates LLC | 31 Mar 2025 | ||
| MOFG | MIDWESTONE FINANCIAL GROUP I | Common Stock | 2.5% | $19,941,460 | -$31,479,024 | 517,960 | -61% | Jennison Associates LLC | 31 Dec 2025 |
| CAVA | CAVA GROUP INC | Common Stock | 0% | $202,192 | -$386,189,531 | 3,347 | -100% | Jennison Associates LLC | 30 Sep 2025 |
| PHAT | PHATHOM PHARMACEUTICALS INC | Common Stock | 0% | $0 | 0 | Jennison Associates LLC | 31 May 2025 |
Schedules 13D/G Reported by JENNISON ASSOCIATES LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.